Understanding the Multiple Effects of PCBs on Lipid Metabolism

References

• Desforges JP, Hall A. Predicting global killer whale population collapse from PCB pollution. Science. 2018;361(6409):1373–1376.
   PubMed Web of Science ®Google Scholar
• Raffetti E, Donato F, Speziani F, Scarcella C, Gaia A, Magoni M. Polychlorinated biphenyls (PCBs) exposure and cardiovascular, endocrine and metabolic diseases: a population-based cohort study in a North Italian highly polluted area. Environ Int. 2018;120:215–222. doi:10.1016/j.envint.2018.08.022
   PubMedGoogle Scholar
• Gao Q, Ben Y, Dong Z, Hu J. Age-dependent human elimination half-lives of dioxin-like polychlorinated biphenyls derived from biomonitoring data in the general population. Chemosphere. 2019;222:541–548.
   PubMedGoogle Scholar
• Wu WL, Deng XL, Zhou SJ, et al. Levels, congener profiles, and dietary intake assessment of polychlorinated dibenzo-p-dioxins/dibenzofurans and dioxin-like polychlorinated biphenyls in beef, freshwater fish, and pork marketed in Guangdong Province, China. Sci Total Environ. 2018;615:412–421. doi:10.1016/j.scitotenv.2017.09.273
   PubMed Web of Science ®Google Scholar
• Yang L, Jin F, Liu G, et al. Levels and characteristics of polychlorinated biphenyls in surface sediments of the Chaobai river, a source of drinking water for Beijing, China. Ecotoxicol Environ Saf. 2019;109922.
   PubMedGoogle Scholar
• Cui S, Fu Q, Ma WL, Song WW, Liu LY, Li YF. A preliminary compilation and evaluation of a comprehensive emission inventory for polychlorinated biphenyls in China. Sci Total Environ. 2015;533:247–255. doi:10.1016/j.scitotenv.2015.06.144
   PubMed Web of Science ®Google Scholar
• Heindel JJ, Blumberg B, Cave M, et al. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33. doi:10.1016/j.reprotox.2016.10.001
   PubMed Web of Science ®Google Scholar
• Armstrong LE, Guo GL. Understanding environmental contaminants’ direct effects on non-alcoholic fatty liver disease progression. Curr Environ Health Rep. 2019;6(3):95–104. doi:10.1007/s40572-019-00231-x
   PubMedGoogle Scholar
• Boucher MP, Lefebvre C, Chapados NA. The effects of PCB126 on intra-hepatic mechanisms associated with non alcoholic fatty liver disease. J Diabetes Metab Disord. 2015;14(1):88. doi:10.1186/s40200-015-0218-2
   PubMedGoogle Scholar
• Arsenescu V, Arsenescu R, Parulkar M, et al. Polychlorinated biphenyl 77 augments angiotensin II-induced atherosclerosis and abdominal aortic aneurysms in male apolipoprotein E deficient mice. Toxicol Appl Pharmacol. 2011;257(1):148–154. doi:10.1016/j.taap.2011.08.028
   PubMedGoogle Scholar
• Chi Y, Lin Y, Lu Y, Huang Q, Ye G, Dong S. Gut microbiota dysbiosis correlates with a low-dose PCB126-induced dyslipidemia and non-alcoholic fatty liver disease. Sci Total Environ. 2019;653:274–282. doi:10.1016/j.scitotenv.2018.10.387
   PubMedGoogle Scholar
• Loiola RA, Dos Anjos FM, Shimada AL, et al. Long-term in vivo polychlorinated biphenyl 126 exposure induces oxidative stress and alters proteomic profile on islets of Langerhans. Sci Rep. 2016;6(1):27882. doi:10.1038/srep27882
   PubMedGoogle Scholar
• Wahlang B, Falkner KC, Gregory B, et al. Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. J Nutr Biochem. 2013;24(9):1587–1595. doi:10.1016/j.jnutbio.2013.01.009
   PubMed Web of Science ®Google Scholar
• Whysner J, Wang CX. Hepatocellular iron accumulation and increased cell proliferation in polychlorinated biphenyl-exposed sprague-dawley rats and the development of hepatocarcinogenesis. Toxicol Sci. 2001;62(1):36–45. doi:10.1093/toxsci/62.1.36
   PubMedGoogle Scholar
• La Merrill M, Emond C, Kim MJ, et al. Toxicological function of adipose tissue: focus on persistent organic pollutants. Environ Health Perspect. 2013;121(2):162–169. doi:10.1289/ehp.1205485
   PubMed Web of Science ®Google Scholar
• Chevrier J, Dewailly E, Ayotte P, Mauriege P, Despres JP, Tremblay A. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord. 2000;24(10):1272–1278. doi:10.1038/sj.ijo.0801380
   PubMedGoogle Scholar
• Kim MJ, Marchand P, Henegar C, et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ Health Perspect. 2011;119(3):377–383. doi:10.1289/ehp.1002848
   PubMed Web of Science ®Google Scholar
• Bumpus TW, Baskin JM. Greasing the wheels of lipid biology with chemical tools. Trends Biochem Sci. 2018;43(12):970–983. doi:10.1016/j.tibs.2018.09.011
   PubMedGoogle Scholar
• Snaebjornsson MT, Janaki-Raman S, Schulze A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 2019.
   PubMedGoogle Scholar
• Tumanov S, Kamphorst JJ. Recent advances in expanding the coverage of the lipidome. Curr Opin Biotechnol. 2017;43:127–133. doi:10.1016/j.copbio.2016.11.008
   PubMedGoogle Scholar
• Wang SP, Yang H, Wu JW, Gauthier N, Fukao T, Mitchell GA. Metabolism as a tool for understanding human brain evolution: lipid energy metabolism as an example. J Hum Evol. 2014;77:41–49. doi:10.1016/j.jhevol.2014.06.013
   PubMedGoogle Scholar
• Palomer X, Barroso E, Zarei M, Botteri G, Vazquez-Carrera M. PPARbeta/delta and lipid metabolism in the heart. Biochim Biophys Acta. 2016;1861(10):1569–1578. doi:10.1016/j.bbalip.2016.01.019
   PubMedGoogle Scholar
• Alves-Bezerra M, Cohen DE. Triglyceride metabolism in the liver. Compr Physiol. 2017;8(1):1–8.
   PubMed Web of Science ®Google Scholar
• Sunami Y, Rebelo A, Kleeff J. Lipid metabolism and lipid droplets in pancreatic cancer and stellate cells. Cancers. 2017;10(1):3. doi:10.3390/cancers10010003
   PubMedGoogle Scholar
• Zhao L, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. CD36 and lipid metabolism in the evolution of atherosclerosis. Br Med Bull. 2018;126(1):101–112. doi:10.1093/bmb/ldy006
   PubMed Web of Science ®Google Scholar
• Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z. Lipid accumulation and chronic kidney disease. Nutrients. 2019;11(4):722. doi:10.3390/nu11040722
   PubMed Web of Science ®Google Scholar
• Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76(1):99–128.
   PubMed Web of Science ®Google Scholar
• Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol. 2013;48(4):434–441. doi:10.1007/s00535-013-0758-5
   PubMed Web of Science ®Google Scholar
• Knebel B, Fahlbusch P, Dille M, et al. Fatty liver due to increased de novo lipogenesis: alterations in the hepatic peroxisomal proteome. Front Cell Dev Biol. 2019;7:248. doi:10.3389/fcell.2019.00248
   PubMedGoogle Scholar
• Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism. 2014;63(7):895–902. doi:10.1016/j.metabol.2014.04.003
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343–1351. doi:10.1172/JCI23621
   PubMed Web of Science ®Google Scholar
• Shi H, Jan J, Hardesty JE, et al. Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: implications for nonalcoholic steatohepatitis and diabetes. Toxicol Appl Pharmacol. 2019;363:22–33.
   PubMedGoogle Scholar
• Wahlang B, Hardesty JE, Jin J, Falkner KC, Cave MC. Polychlorinated biphenyls and nonalcoholic fatty liver disease. Curr Opin Toxicol. 2019;14:21–28. doi:10.1016/j.cotox.2019.06.001
   PubMedGoogle Scholar
• Safe S, Bandiera S, Sawyer T, et al. PCBs: structure-function relationships and mechanism of action. Environ Health Perspect. 1985;60:47–56.
   PubMed Web of Science ®Google Scholar
• Larigot L, Juricek L, Dairou J, Coumoul X. AhR signaling pathways and regulatory functions. Biochim Open. 2018;7:1–9.
   PubMedGoogle Scholar
• Petriello MC, Hoffman JB, Sunkara M, et al. Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors. J Nutr Biochem. 2016;33:145–153. doi:10.1016/j.jnutbio.2016.03.016
   PubMed Web of Science ®Google Scholar
• Ruan J, Guo J, Huang Y, Mao Y, Yang Z, Zuo Z. Adolescent exposure to environmental level of PCBs (aroclor 1254) induces non-alcoholic fatty liver disease in male mice. Environ Res. 2019;108909.
   PubMedGoogle Scholar
• Xu CX, Wang C, Zhang ZM, et al. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure. Int J Obes (Lond). 2015;39(8):1300–1309. doi:10.1038/ijo.2015.63
   PubMed Web of Science ®Google Scholar
• Boverhof DR, Burgoon LD, Tashiro C, et al. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in sprague dawley rats and C57BL/6 mice. Toxicol Sci. 2006;94(2):398–416. doi:10.1093/toxsci/kfl100
   PubMedGoogle Scholar
• Nebert DW, Roe AL, Dieter MZ, Solis WA, Yang Y, Dalton TP. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol. 2000;59(1):65–85. doi:10.1016/S0006-2952(99)00310-X
   PubMed Web of Science ®Google Scholar
• Newsome BJ, Petriello MC, Han SG, et al. Green tea diet decreases PCB 126-induced oxidative stress in mice by up-regulating antioxidant enzymes. J Nutr Biochem. 2014;25(2):126–135. doi:10.1016/j.jnutbio.2013.10.003
   PubMed Web of Science ®Google Scholar
• Lim EJ, Majkova Z, Xu S, et al. Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated through caveolae signaling in vascular endothelial cells. Chem Biol Interact. 2008;176(2–3):71–78. doi:10.1016/j.cbi.2008.08.007
   PubMedGoogle Scholar
• Kawano Y, Nishiumi S, Tanaka S, et al. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport. Arch Biochem Biophys. 2010;504(2):221–227. doi:10.1016/j.abb.2010.09.001
   PubMed Web of Science ®Google Scholar
• Wahlang B, Perkins JT, Petriello MC, Hoffman JB, Stromberg AJ, Hennig B. A compromised liver alters polychlorinated biphenyl-mediated toxicity. Toxicology. 2017;380:11–22. doi:10.1016/j.tox.2017.02.001
   PubMed Web of Science ®Google Scholar
• Tolson AH, Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev. 2010;62(13):1238–1249. doi:10.1016/j.addr.2010.08.006
   PubMed Web of Science ®Google Scholar
• Al-Salman F, Plant N. Non-coplanar polychlorinated biphenyls (PCBs) are direct agonists for the human pregnane-X receptor and constitutive androstane receptor, and activate target gene expression in a tissue-specific manner. Toxicol Appl Pharmacol. 2012;263(1):7–13. doi:10.1016/j.taap.2012.05.016
   PubMedGoogle Scholar
• Wahlang B, Falkner KC, Clair HB, et al. Human receptor activation by aroclor 1260, a polychlorinated biphenyl mixture. Toxicol Sci. 2014;140(2):283–297. doi:10.1093/toxsci/kfu083
   PubMed Web of Science ®Google Scholar
• Wahlang B, Song M, Beier JI, et al. Evaluation of aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease. Toxicol Appl Pharmacol. 2014;279(3):380–390. doi:10.1016/j.taap.2014.06.019
   PubMed Web of Science ®Google Scholar
• Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev. 2002;23(5):687–702.
   PubMed Web of Science ®Google Scholar
• Xu P, Zhai Y, Wang J. The role of PPAR and its cross-talk with CAR and LXR in obesity and atherosclerosis. Int J Mol Sci. 2018;19(4):1260. doi:10.3390/ijms19041260
   PubMedGoogle Scholar
• Xiao L, Xie X, Zhai Y. Functional crosstalk of CAR–LXR and ROR–LXR in drug metabolism and lipid metabolism. Adv Drug Deliv Rev. 2010;62(13):1316–1321. doi:10.1016/j.addr.2010.07.006
   PubMedGoogle Scholar
• Zhou J, Febbraio M, Wada T, et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology. 2008;134(2):556–567. doi:10.1053/j.gastro.2007.11.037
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93(2):241–252. doi:10.1016/S0092-8674(00)81575-5
   PubMed Web of Science ®Google Scholar
• Roth A, Looser R, Kaufmann M, et al. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression. Mol Pharmacol. 2008;73(4):1282–1289. doi:10.1124/mol.107.041012
   PubMed Web of Science ®Google Scholar
• Wahlang B, Prough RA, Falkner KC, et al. Polychlorinated biphenyl-xenobiotic nuclear receptor interactions regulate energy metabolism, behavior, and inflammation in non-alcoholic-steatohepatitis. Toxicol Sci. 2016;149(2):396–410. doi:10.1093/toxsci/kfv250
   PubMedGoogle Scholar
• Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996;137(1):354–366. doi:10.1210/endo.137.1.8536636
   PubMed Web of Science ®Google Scholar
• Drew PD, Xu J, Storer PD, Chavis JA, Racke MK. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int. 2006;49(2):183–189. doi:10.1016/j.neuint.2006.04.003
   PubMed Web of Science ®Google Scholar
• Liss KHH, Finck BN. PPARs and nonalcoholic fatty liver disease. Biochimie. 2017;136:65–74. doi:10.1016/j.biochi.2016.11.009
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1–26. doi:10.1016/j.plipres.2008.08.001
   PubMed Web of Science ®Google Scholar
• Hardesty JE, Wahlang B, Falkner KC. Proteomic analysis reveals novel mechanisms by which polychlorinated biphenyls compromise the liver promoting diet-induced steatohepatitis. J Proteome Res. 2019;18(4):1582–1594. doi:10.1021/acs.jproteome.8b00886
   PubMedGoogle Scholar
• Chen N, Shan Q, Qi Y, Liu W, Tan X, Gu J. Transcriptome analysis in normal human liver cells exposed to 2, 3, 3ʹ, 4, 4ʹ, 5 - hexachlorobiphenyl (PCB 156). Chemosphere. 2019;239:124747. doi:10.1016/j.chemosphere.2019.124747
   PubMedGoogle Scholar
• Chi Y, Wang H, Lin Y, et al. Gut microbiota characterization and lipid metabolism disorder found in PCB77-treated female mice. Toxicology. 2019;420:11–20. doi:10.1016/j.tox.2019.03.011
   PubMedGoogle Scholar
• Wahlang B, Barney J, Thompson B, et al. Editor’s highlight: PCB126 exposure increases risk for peripheral vascular diseases in a liver injury mouse model. Toxicol Sci. 2017;160(2):256–267.
   PubMedGoogle Scholar
• Ruiz R, Jideonwo V, Ahn M, et al. Sterol regulatory element-binding protein-1 (SREBP-1) is required to regulate glycogen synthesis and gluconeogenic gene expression in mouse liver. J Biol Chem. 2014;289(9):5510–5517. doi:10.1074/jbc.M113.541110
   PubMed Web of Science ®Google Scholar
• Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest. 1997;99(5):846–854. doi:10.1172/JCI119248
   PubMed Web of Science ®Google Scholar
• Wu H, Yu W, Meng F, et al. Polychlorinated biphenyls-153 induces metabolic dysfunction through activation of ROS/NF-kappaB signaling via downregulation of HNF1b. Redox Biol. 2017;12:300–310. doi:10.1016/j.redox.2017.02.026
   PubMed Web of Science ®Google Scholar
• Savage DB, Choi CS, Samuel VT, et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest. 2006;116(3):817–824. doi:10.1172/JCI27300
   PubMed Web of Science ®Google Scholar
• Dobrzyn P, Dobrzyn A, Miyazaki M, et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A. 2004;101(17):6409–6414. doi:10.1073/pnas.0401627101
   PubMed Web of Science ®Google Scholar
• Shen X, Chen Y, Zhang J, et al. Low-dose PCB126 compromises circadian rhythms associated with disordered glucose and lipid metabolism in mice. Environ Int. 2019;128:146–157. doi:10.1016/j.envint.2019.04.058
   PubMed Web of Science ®Google Scholar
• Stone SJ, Myers HM, Watkins SM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem. 2004;279(12):11767–11776. doi:10.1074/jbc.M311000200
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Yang L, McCall S, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology. 2007;45(6):1366–1374. doi:10.1002/hep.21655
   PubMed Web of Science ®Google Scholar
• Juarez-Hernandez E, Chavez-Tapia NC, Uribe M, Barbero-Becerra VJ. Role of bioactive fatty acids in nonalcoholic fatty liver disease. Nutr J. 2016;15(1):72. doi:10.1186/s12937-016-0191-8
   PubMedGoogle Scholar
• Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679–689. doi:10.1002/hep.23280
   PubMed Web of Science ®Google Scholar
• van der Vusse GJ. Albumin as fatty acid transporter. Drug Metab Pharmacokinet. 2009;24(4):300–307. doi:10.2133/dmpk.24.300
   PubMed Web of Science ®Google Scholar
• Glatz JF, Luiken JJ, van Nieuwenhoven FA, Van der Vusse GJ. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandins Leukot Essent Fatty Acids. 1997;57(1):3–9. doi:10.1016/S0952-3278(97)90485-3
   PubMedGoogle Scholar
• Pepino MY, Kuda O, Samovski D, Abumrad NA. Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism. Annu Rev Nutr. 2014;34(1):281–303. doi:10.1146/annurev-nutr-071812-161220
   PubMedGoogle Scholar
• Abumrad NA, el-Maghrabi MR, Amri EZ, Lopez E, Grimaldi PA. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem. 1993;268(24):17665–17668.
   PubMed Web of Science ®Google Scholar
• Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem. 2000;275(42):32523–32529. doi:10.1074/jbc.M003826200
   PubMed Web of Science ®Google Scholar
• Hirano K, Kuwasako T, Nakagawa-Toyama Y, Janabi M, Yamashita S, Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med. 2003;13(4):136–141. doi:10.1016/S1050-1738(03)00026-4
   PubMed Web of Science ®Google Scholar
• Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology. 2016;157(2):570–585. doi:10.1210/en.2015-1866
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang C, Luo X, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018;69(3):705–717. doi:10.1016/j.jhep.2018.04.006
   PubMed Web of Science ®Google Scholar
• Ding D, Ye G, Lin Y, et al. MicroRNA-26a-CD36 signaling pathway: pivotal role in lipid accumulation in hepatocytes induced by PM2.5 liposoluble extracts. Environ Pollut. 2019;248:269–278. doi:10.1016/j.envpol.2019.01.112
   PubMedGoogle Scholar
• Wahlang B, Jin J, Hardesty JE, et al. Identifying sex differences arising from polychlorinated biphenyl exposures in toxicant-associated liver disease. Food Chem Toxicol. 2019;129:64–76.
   PubMedGoogle Scholar
• Chapados NA, Boucher MP. Liver metabolic disruption induced after a single exposure to PCB126 in rats. Environ Sci Pollut Res Int. 2017;24(2):1854–1861. doi:10.1007/s11356-016-7939-8
   PubMedGoogle Scholar
• Gadupudi GS, Elser BA, Sandgruber FA, Li X, Gibson-Corley KN, Robertson LW. PCB126 inhibits the activation of AMPK-CREB signal transduction required for energy sensing in liver. Toxicol Sci. 2018;163(2):440–453. doi:10.1093/toxsci/kfy041
   PubMed Web of Science ®Google Scholar